Streamlining Hematology eviCore Integration for Advanced Therapies

Navigating the complexities of prior authorizations for hematology services, especially those managed by eviCore, demands precision and efficiency. Klivira's platform provides a robust solution for hematology eviCore integration, automating critical steps in the PA workflow.

Hematology practices face unique challenges in prior authorization, from high-cost factor concentrates to advanced imaging for diagnosis and staging of hematologic cancers. eviCore Healthcare, a prominent benefit management company, often oversees prior authorization for radiology, cardiology, and oncology services that are integral to hematology care. Optimizing this integration is crucial for maintaining revenue cycle health and ensuring timely patient access to essential treatments and diagnostics.

The Intersection of Hematology and eviCore PA Requirements

eviCore primarily manages prior authorizations for advanced imaging and certain specialty services, which are frequently utilized in hematology. This includes PET/CT scans, MRIs, and other diagnostic procedures for conditions such as multiple myeloma, lymphoma, and venous thromboembolism (VTE). While eviCore's role is broad, its radiology benefit management directly impacts the diagnostic and staging pathways for many hematologic disorders, necessitating a streamlined approach to prior authorization.

Key Prior Authorization Triggers in Hematology Managed by eviCore

Within hematology, eviCore's review typically focuses on advanced diagnostic imaging required for initial workup, staging, and monitoring of various conditions. Specific PA triggers include specialty imaging for suspected or confirmed hematologic malignancies, such as lymphomas and leukemias, and for assessing treatment response. While eviCore's primary focus is often radiology, its broader scope in oncology benefit management can also touch upon certain advanced therapies within hematologic oncology.

Common eviCore-Managed Services in Hematology

  • Advanced imaging for multiple myeloma and MGUS workup
  • PET/CT and MRI for lymphoma and leukemia staging and restaging
  • Diagnostic imaging for venous thromboembolism (VTE)
  • CT scans for evaluation of bleeding disorders or organ involvement
  • Imaging for bone marrow and stem cell transplant evaluation

Optimizing EMR and Payer Touchpoints for eviCore Submissions

Effective hematology eviCore integration requires seamless data flow between your EMR and payer channels. Klivira facilitates the automated extraction of necessary clinical documentation, such as ASH guidelines for hemophilia factor or NCCN guidelines for hematologic oncology, directly from the EMR. This data is then structured for electronic submission via X12 278 or payer portals, reducing manual data entry and ensuring all required information for eviCore's review is accurately transmitted.

Klivira's Approach to Hematology eviCore Integration

Klivira's platform is engineered to automate the prior authorization workflow for hematology services, including those managed by eviCore. Our system leverages ASH/NCCN-aware policy logic to identify documentation requirements for high-cost factor concentrates, sickle cell specialty drugs, and CAR-T cell therapies, as well as for advanced imaging. By connecting directly with EMRs and payer portals, we ensure that the specific clinical data points eviCore requires for radiology benefit management are accurately captured and submitted, minimizing common denial reasons related to documentation gaps.

Addressing Documentation Requirements and Clinical Guidelines

Prior authorizations for hematology, especially those involving eviCore, are heavily reliant on robust clinical documentation. For hematologic oncology, adherence to NCCN guidelines is paramount. For conditions like hemophilia, factor level documentation and bleeding episode tracking are critical. Klivira's system is designed to identify and compile these specific documentation elements, ensuring that your submissions meet the evidence-based criteria often required by eviCore and other payers, thereby accelerating approval times.

Frequently asked questions

Which hematology services typically require prior authorization through eviCore?

eviCore primarily manages prior authorizations for advanced diagnostic imaging, such as PET/CT, MRI, and CT scans, which are frequently used in hematology for diagnosing, staging, and monitoring conditions like multiple myeloma, lymphoma, leukemia, and VTE. While Klivira also supports PA for specialty drugs, eviCore's direct impact on hematology often centers on radiology benefit management.

How does Klivira improve the eviCore prior authorization process for hematology practices?

Klivira automates the extraction of clinical data from your EMR, applies specific policy logic based on ASH and NCCN guidelines, and facilitates electronic submission to eviCore via X12 278 or their portal. This reduces manual effort, improves data accuracy, and helps ensure that all necessary documentation for hematology-related imaging and therapies is present for a faster review.

What documentation is crucial for eviCore PA submissions in hematology?

Key documentation includes physician orders, clinical notes detailing diagnosis and medical necessity, relevant lab results (e.g., factor levels, genetic markers), and imaging reports. For hematologic oncology, adherence to NCCN guidelines is critical, while for other blood disorders, specific ASH guidelines may apply. Klivira helps ensure these are compiled efficiently.

Can Klivira integrate with our existing EMR for hematology eviCore submissions?

Yes, Klivira is designed for deep integration with leading EMR systems. This allows for automated data extraction and transfer of clinical information directly from your EMR to support eviCore prior authorization requests for hematology services, minimizing disruption to your existing clinical workflows.

How does eviCore's role in oncology benefit management affect hematologic oncology?

eviCore's oncology benefit management can encompass certain advanced therapies and diagnostic imaging crucial for hematologic oncology, such as lymphomas, leukemias, and multiple myeloma. Klivira's platform is equipped to handle the complex documentation and guideline adherence, like NCCN criteria for CAR-T cell therapies, required for these submissions, streamlining the process with eviCore.

Related coverage

Other hematology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo